The association between plasma proteomics and incident cardiovascular disease identifies MMP-12 as a promising cardiovascular risk marker in patients with chronic kidney disease
Previous proteomics efforts in patients with chronic kidney disease (CKD) have predominantly evaluated urinary protein levels. Therefore, our aim was to investigate the association between plasma levels of 80 cardiovascular disease-related proteins and the risk of major adverse cardiovascular events...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Feldreich, Tobias [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2020 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
5 |
|---|
| Übergeordnetes Werk: |
Enthalten in: No title available - 307(2020), Seite 11-15 |
|---|---|
| Übergeordnetes Werk: |
volume:307 ; year:2020 ; pages:11-15 ; extent:5 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.atherosclerosis.2020.06.013 |
|---|
| Katalog-ID: |
ELV051237261 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV051237261 | ||
| 003 | DE-627 | ||
| 005 | 20230624172746.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210910s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.atherosclerosis.2020.06.013 |2 doi | |
| 028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001120.pica |
| 035 | |a (DE-627)ELV051237261 | ||
| 035 | |a (ELSEVIER)S0021-9150(20)30320-8 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Feldreich, Tobias |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The association between plasma proteomics and incident cardiovascular disease identifies MMP-12 as a promising cardiovascular risk marker in patients with chronic kidney disease |
| 264 | 1 | |c 2020 | |
| 300 | |a 5 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Previous proteomics efforts in patients with chronic kidney disease (CKD) have predominantly evaluated urinary protein levels. Therefore, our aim was to investigate the association between plasma levels of 80 cardiovascular disease-related proteins and the risk of major adverse cardiovascular events (MACE) in patients with CKD. | ||
| 650 | 7 | |a Cardiovascular risk marker |2 Elsevier | |
| 650 | 7 | |a Major adverse cardiovascular events |2 Elsevier | |
| 650 | 7 | |a Proteomics |2 Elsevier | |
| 650 | 7 | |a Chronic kidney disease |2 Elsevier | |
| 650 | 7 | |a Community-based cohorts |2 Elsevier | |
| 700 | 1 | |a Nowak, Christoph |4 oth | |
| 700 | 1 | |a Carlsson, Axel C. |4 oth | |
| 700 | 1 | |a Östgren, Carl-Johan |4 oth | |
| 700 | 1 | |a Nyström, Fredrik H. |4 oth | |
| 700 | 1 | |a Sundström, Johan |4 oth | |
| 700 | 1 | |a Carrero-Roig, Juan-Jesus |4 oth | |
| 700 | 1 | |a Leppert, Jerzy |4 oth | |
| 700 | 1 | |a Hedberg, Pär |4 oth | |
| 700 | 1 | |a Giedraitis, Vilmantas |4 oth | |
| 700 | 1 | |a Lind, Lars |4 oth | |
| 700 | 1 | |a Cordeiro, Antonio |4 oth | |
| 700 | 1 | |a Ärnlöv, Johan |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t No title available |g 307(2020), Seite 11-15 |w (DE-627)ELV012595616 |w (DE-600)1-9150 |7 nnns |
| 773 | 1 | 8 | |g volume:307 |g year:2020 |g pages:11-15 |g extent:5 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.atherosclerosis.2020.06.013 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a GBV_ILN_40 | ||
| 912 | |a GBV_ILN_105 | ||
| 951 | |a AR | ||
| 952 | |d 307 |j 2020 |h 11-15 |g 5 | ||
| author_variant |
t f tf |
|---|---|
| matchkey_str |
feldreichtobiasnowakchristophcarlssonaxe:2020----:hascainewepampoemcadnietadoaclriesietfemp2spoiigadoaclrik |
| hierarchy_sort_str |
2020 |
| publishDate |
2020 |
| allfields |
10.1016/j.atherosclerosis.2020.06.013 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001120.pica (DE-627)ELV051237261 (ELSEVIER)S0021-9150(20)30320-8 DE-627 ger DE-627 rakwb eng Feldreich, Tobias verfasserin aut The association between plasma proteomics and incident cardiovascular disease identifies MMP-12 as a promising cardiovascular risk marker in patients with chronic kidney disease 2020 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Previous proteomics efforts in patients with chronic kidney disease (CKD) have predominantly evaluated urinary protein levels. Therefore, our aim was to investigate the association between plasma levels of 80 cardiovascular disease-related proteins and the risk of major adverse cardiovascular events (MACE) in patients with CKD. Cardiovascular risk marker Elsevier Major adverse cardiovascular events Elsevier Proteomics Elsevier Chronic kidney disease Elsevier Community-based cohorts Elsevier Nowak, Christoph oth Carlsson, Axel C. oth Östgren, Carl-Johan oth Nyström, Fredrik H. oth Sundström, Johan oth Carrero-Roig, Juan-Jesus oth Leppert, Jerzy oth Hedberg, Pär oth Giedraitis, Vilmantas oth Lind, Lars oth Cordeiro, Antonio oth Ärnlöv, Johan oth Enthalten in No title available 307(2020), Seite 11-15 (DE-627)ELV012595616 (DE-600)1-9150 nnns volume:307 year:2020 pages:11-15 extent:5 https://doi.org/10.1016/j.atherosclerosis.2020.06.013 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_20 GBV_ILN_40 GBV_ILN_105 AR 307 2020 11-15 5 |
| spelling |
10.1016/j.atherosclerosis.2020.06.013 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001120.pica (DE-627)ELV051237261 (ELSEVIER)S0021-9150(20)30320-8 DE-627 ger DE-627 rakwb eng Feldreich, Tobias verfasserin aut The association between plasma proteomics and incident cardiovascular disease identifies MMP-12 as a promising cardiovascular risk marker in patients with chronic kidney disease 2020 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Previous proteomics efforts in patients with chronic kidney disease (CKD) have predominantly evaluated urinary protein levels. Therefore, our aim was to investigate the association between plasma levels of 80 cardiovascular disease-related proteins and the risk of major adverse cardiovascular events (MACE) in patients with CKD. Cardiovascular risk marker Elsevier Major adverse cardiovascular events Elsevier Proteomics Elsevier Chronic kidney disease Elsevier Community-based cohorts Elsevier Nowak, Christoph oth Carlsson, Axel C. oth Östgren, Carl-Johan oth Nyström, Fredrik H. oth Sundström, Johan oth Carrero-Roig, Juan-Jesus oth Leppert, Jerzy oth Hedberg, Pär oth Giedraitis, Vilmantas oth Lind, Lars oth Cordeiro, Antonio oth Ärnlöv, Johan oth Enthalten in No title available 307(2020), Seite 11-15 (DE-627)ELV012595616 (DE-600)1-9150 nnns volume:307 year:2020 pages:11-15 extent:5 https://doi.org/10.1016/j.atherosclerosis.2020.06.013 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_20 GBV_ILN_40 GBV_ILN_105 AR 307 2020 11-15 5 |
| allfields_unstemmed |
10.1016/j.atherosclerosis.2020.06.013 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001120.pica (DE-627)ELV051237261 (ELSEVIER)S0021-9150(20)30320-8 DE-627 ger DE-627 rakwb eng Feldreich, Tobias verfasserin aut The association between plasma proteomics and incident cardiovascular disease identifies MMP-12 as a promising cardiovascular risk marker in patients with chronic kidney disease 2020 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Previous proteomics efforts in patients with chronic kidney disease (CKD) have predominantly evaluated urinary protein levels. Therefore, our aim was to investigate the association between plasma levels of 80 cardiovascular disease-related proteins and the risk of major adverse cardiovascular events (MACE) in patients with CKD. Cardiovascular risk marker Elsevier Major adverse cardiovascular events Elsevier Proteomics Elsevier Chronic kidney disease Elsevier Community-based cohorts Elsevier Nowak, Christoph oth Carlsson, Axel C. oth Östgren, Carl-Johan oth Nyström, Fredrik H. oth Sundström, Johan oth Carrero-Roig, Juan-Jesus oth Leppert, Jerzy oth Hedberg, Pär oth Giedraitis, Vilmantas oth Lind, Lars oth Cordeiro, Antonio oth Ärnlöv, Johan oth Enthalten in No title available 307(2020), Seite 11-15 (DE-627)ELV012595616 (DE-600)1-9150 nnns volume:307 year:2020 pages:11-15 extent:5 https://doi.org/10.1016/j.atherosclerosis.2020.06.013 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_20 GBV_ILN_40 GBV_ILN_105 AR 307 2020 11-15 5 |
| allfieldsGer |
10.1016/j.atherosclerosis.2020.06.013 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001120.pica (DE-627)ELV051237261 (ELSEVIER)S0021-9150(20)30320-8 DE-627 ger DE-627 rakwb eng Feldreich, Tobias verfasserin aut The association between plasma proteomics and incident cardiovascular disease identifies MMP-12 as a promising cardiovascular risk marker in patients with chronic kidney disease 2020 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Previous proteomics efforts in patients with chronic kidney disease (CKD) have predominantly evaluated urinary protein levels. Therefore, our aim was to investigate the association between plasma levels of 80 cardiovascular disease-related proteins and the risk of major adverse cardiovascular events (MACE) in patients with CKD. Cardiovascular risk marker Elsevier Major adverse cardiovascular events Elsevier Proteomics Elsevier Chronic kidney disease Elsevier Community-based cohorts Elsevier Nowak, Christoph oth Carlsson, Axel C. oth Östgren, Carl-Johan oth Nyström, Fredrik H. oth Sundström, Johan oth Carrero-Roig, Juan-Jesus oth Leppert, Jerzy oth Hedberg, Pär oth Giedraitis, Vilmantas oth Lind, Lars oth Cordeiro, Antonio oth Ärnlöv, Johan oth Enthalten in No title available 307(2020), Seite 11-15 (DE-627)ELV012595616 (DE-600)1-9150 nnns volume:307 year:2020 pages:11-15 extent:5 https://doi.org/10.1016/j.atherosclerosis.2020.06.013 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_20 GBV_ILN_40 GBV_ILN_105 AR 307 2020 11-15 5 |
| allfieldsSound |
10.1016/j.atherosclerosis.2020.06.013 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001120.pica (DE-627)ELV051237261 (ELSEVIER)S0021-9150(20)30320-8 DE-627 ger DE-627 rakwb eng Feldreich, Tobias verfasserin aut The association between plasma proteomics and incident cardiovascular disease identifies MMP-12 as a promising cardiovascular risk marker in patients with chronic kidney disease 2020 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Previous proteomics efforts in patients with chronic kidney disease (CKD) have predominantly evaluated urinary protein levels. Therefore, our aim was to investigate the association between plasma levels of 80 cardiovascular disease-related proteins and the risk of major adverse cardiovascular events (MACE) in patients with CKD. Cardiovascular risk marker Elsevier Major adverse cardiovascular events Elsevier Proteomics Elsevier Chronic kidney disease Elsevier Community-based cohorts Elsevier Nowak, Christoph oth Carlsson, Axel C. oth Östgren, Carl-Johan oth Nyström, Fredrik H. oth Sundström, Johan oth Carrero-Roig, Juan-Jesus oth Leppert, Jerzy oth Hedberg, Pär oth Giedraitis, Vilmantas oth Lind, Lars oth Cordeiro, Antonio oth Ärnlöv, Johan oth Enthalten in No title available 307(2020), Seite 11-15 (DE-627)ELV012595616 (DE-600)1-9150 nnns volume:307 year:2020 pages:11-15 extent:5 https://doi.org/10.1016/j.atherosclerosis.2020.06.013 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_20 GBV_ILN_40 GBV_ILN_105 AR 307 2020 11-15 5 |
| language |
English |
| source |
Enthalten in No title available 307(2020), Seite 11-15 volume:307 year:2020 pages:11-15 extent:5 |
| sourceStr |
Enthalten in No title available 307(2020), Seite 11-15 volume:307 year:2020 pages:11-15 extent:5 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Cardiovascular risk marker Major adverse cardiovascular events Proteomics Chronic kidney disease Community-based cohorts |
| isfreeaccess_bool |
false |
| container_title |
No title available |
| authorswithroles_txt_mv |
Feldreich, Tobias @@aut@@ Nowak, Christoph @@oth@@ Carlsson, Axel C. @@oth@@ Östgren, Carl-Johan @@oth@@ Nyström, Fredrik H. @@oth@@ Sundström, Johan @@oth@@ Carrero-Roig, Juan-Jesus @@oth@@ Leppert, Jerzy @@oth@@ Hedberg, Pär @@oth@@ Giedraitis, Vilmantas @@oth@@ Lind, Lars @@oth@@ Cordeiro, Antonio @@oth@@ Ärnlöv, Johan @@oth@@ |
| publishDateDaySort_date |
2020-01-01T00:00:00Z |
| hierarchy_top_id |
ELV012595616 |
| id |
ELV051237261 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV051237261</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624172746.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">210910s2020 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.atherosclerosis.2020.06.013</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001120.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV051237261</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0021-9150(20)30320-8</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Feldreich, Tobias</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The association between plasma proteomics and incident cardiovascular disease identifies MMP-12 as a promising cardiovascular risk marker in patients with chronic kidney disease</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2020</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">5</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Previous proteomics efforts in patients with chronic kidney disease (CKD) have predominantly evaluated urinary protein levels. Therefore, our aim was to investigate the association between plasma levels of 80 cardiovascular disease-related proteins and the risk of major adverse cardiovascular events (MACE) in patients with CKD.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cardiovascular risk marker</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Major adverse cardiovascular events</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Proteomics</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Chronic kidney disease</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Community-based cohorts</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nowak, Christoph</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Carlsson, Axel C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Östgren, Carl-Johan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nyström, Fredrik H.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sundström, Johan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Carrero-Roig, Juan-Jesus</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Leppert, Jerzy</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hedberg, Pär</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Giedraitis, Vilmantas</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lind, Lars</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cordeiro, Antonio</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ärnlöv, Johan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">No title available</subfield><subfield code="g">307(2020), Seite 11-15</subfield><subfield code="w">(DE-627)ELV012595616</subfield><subfield code="w">(DE-600)1-9150</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:307</subfield><subfield code="g">year:2020</subfield><subfield code="g">pages:11-15</subfield><subfield code="g">extent:5</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.atherosclerosis.2020.06.013</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">307</subfield><subfield code="j">2020</subfield><subfield code="h">11-15</subfield><subfield code="g">5</subfield></datafield></record></collection>
|
| author |
Feldreich, Tobias |
| spellingShingle |
Feldreich, Tobias Elsevier Cardiovascular risk marker Elsevier Major adverse cardiovascular events Elsevier Proteomics Elsevier Chronic kidney disease Elsevier Community-based cohorts The association between plasma proteomics and incident cardiovascular disease identifies MMP-12 as a promising cardiovascular risk marker in patients with chronic kidney disease |
| authorStr |
Feldreich, Tobias |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV012595616 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
The association between plasma proteomics and incident cardiovascular disease identifies MMP-12 as a promising cardiovascular risk marker in patients with chronic kidney disease Cardiovascular risk marker Elsevier Major adverse cardiovascular events Elsevier Proteomics Elsevier Chronic kidney disease Elsevier Community-based cohorts Elsevier |
| topic |
Elsevier Cardiovascular risk marker Elsevier Major adverse cardiovascular events Elsevier Proteomics Elsevier Chronic kidney disease Elsevier Community-based cohorts |
| topic_unstemmed |
Elsevier Cardiovascular risk marker Elsevier Major adverse cardiovascular events Elsevier Proteomics Elsevier Chronic kidney disease Elsevier Community-based cohorts |
| topic_browse |
Elsevier Cardiovascular risk marker Elsevier Major adverse cardiovascular events Elsevier Proteomics Elsevier Chronic kidney disease Elsevier Community-based cohorts |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
c n cn a c c ac acc c j ö cjö f h n fh fhn j s js j j c r jjcr j l jl p h ph v g vg l l ll a c ac j ä jä |
| hierarchy_parent_title |
No title available |
| hierarchy_parent_id |
ELV012595616 |
| hierarchy_top_title |
No title available |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV012595616 (DE-600)1-9150 |
| title |
The association between plasma proteomics and incident cardiovascular disease identifies MMP-12 as a promising cardiovascular risk marker in patients with chronic kidney disease |
| ctrlnum |
(DE-627)ELV051237261 (ELSEVIER)S0021-9150(20)30320-8 |
| title_full |
The association between plasma proteomics and incident cardiovascular disease identifies MMP-12 as a promising cardiovascular risk marker in patients with chronic kidney disease |
| author_sort |
Feldreich, Tobias |
| journal |
No title available |
| journalStr |
No title available |
| lang_code |
eng |
| isOA_bool |
false |
| recordtype |
marc |
| publishDateSort |
2020 |
| contenttype_str_mv |
zzz |
| container_start_page |
11 |
| author_browse |
Feldreich, Tobias |
| container_volume |
307 |
| physical |
5 |
| format_se |
Elektronische Aufsätze |
| author-letter |
Feldreich, Tobias |
| doi_str_mv |
10.1016/j.atherosclerosis.2020.06.013 |
| title_sort |
association between plasma proteomics and incident cardiovascular disease identifies mmp-12 as a promising cardiovascular risk marker in patients with chronic kidney disease |
| title_auth |
The association between plasma proteomics and incident cardiovascular disease identifies MMP-12 as a promising cardiovascular risk marker in patients with chronic kidney disease |
| abstract |
Previous proteomics efforts in patients with chronic kidney disease (CKD) have predominantly evaluated urinary protein levels. Therefore, our aim was to investigate the association between plasma levels of 80 cardiovascular disease-related proteins and the risk of major adverse cardiovascular events (MACE) in patients with CKD. |
| abstractGer |
Previous proteomics efforts in patients with chronic kidney disease (CKD) have predominantly evaluated urinary protein levels. Therefore, our aim was to investigate the association between plasma levels of 80 cardiovascular disease-related proteins and the risk of major adverse cardiovascular events (MACE) in patients with CKD. |
| abstract_unstemmed |
Previous proteomics efforts in patients with chronic kidney disease (CKD) have predominantly evaluated urinary protein levels. Therefore, our aim was to investigate the association between plasma levels of 80 cardiovascular disease-related proteins and the risk of major adverse cardiovascular events (MACE) in patients with CKD. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_20 GBV_ILN_40 GBV_ILN_105 |
| title_short |
The association between plasma proteomics and incident cardiovascular disease identifies MMP-12 as a promising cardiovascular risk marker in patients with chronic kidney disease |
| url |
https://doi.org/10.1016/j.atherosclerosis.2020.06.013 |
| remote_bool |
true |
| author2 |
Nowak, Christoph Carlsson, Axel C. Östgren, Carl-Johan Nyström, Fredrik H. Sundström, Johan Carrero-Roig, Juan-Jesus Leppert, Jerzy Hedberg, Pär Giedraitis, Vilmantas Lind, Lars Cordeiro, Antonio Ärnlöv, Johan |
| author2Str |
Nowak, Christoph Carlsson, Axel C. Östgren, Carl-Johan Nyström, Fredrik H. Sundström, Johan Carrero-Roig, Juan-Jesus Leppert, Jerzy Hedberg, Pär Giedraitis, Vilmantas Lind, Lars Cordeiro, Antonio Ärnlöv, Johan |
| ppnlink |
ELV012595616 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.atherosclerosis.2020.06.013 |
| up_date |
2024-07-06T19:42:36.407Z |
| _version_ |
1803860004211523584 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV051237261</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624172746.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">210910s2020 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.atherosclerosis.2020.06.013</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001120.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV051237261</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0021-9150(20)30320-8</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Feldreich, Tobias</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The association between plasma proteomics and incident cardiovascular disease identifies MMP-12 as a promising cardiovascular risk marker in patients with chronic kidney disease</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2020</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">5</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Previous proteomics efforts in patients with chronic kidney disease (CKD) have predominantly evaluated urinary protein levels. Therefore, our aim was to investigate the association between plasma levels of 80 cardiovascular disease-related proteins and the risk of major adverse cardiovascular events (MACE) in patients with CKD.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cardiovascular risk marker</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Major adverse cardiovascular events</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Proteomics</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Chronic kidney disease</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Community-based cohorts</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nowak, Christoph</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Carlsson, Axel C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Östgren, Carl-Johan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nyström, Fredrik H.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sundström, Johan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Carrero-Roig, Juan-Jesus</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Leppert, Jerzy</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hedberg, Pär</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Giedraitis, Vilmantas</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lind, Lars</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cordeiro, Antonio</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ärnlöv, Johan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">No title available</subfield><subfield code="g">307(2020), Seite 11-15</subfield><subfield code="w">(DE-627)ELV012595616</subfield><subfield code="w">(DE-600)1-9150</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:307</subfield><subfield code="g">year:2020</subfield><subfield code="g">pages:11-15</subfield><subfield code="g">extent:5</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.atherosclerosis.2020.06.013</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">307</subfield><subfield code="j">2020</subfield><subfield code="h">11-15</subfield><subfield code="g">5</subfield></datafield></record></collection>
|
| score |
7.399686 |